A detailed history of Scientech Research LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 43,350 shares of TSHA stock, worth $65,025. This represents 0.02% of its overall portfolio holdings.

Number of Shares
43,350
Holding current value
$65,025
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.04 - $4.17 $88,434 - $180,769
43,350 New
43,350 $97.1 Million

Others Institutions Holding TSHA

About Taysha Gene Therapies, Inc.


  • Ticker TSHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,359,500
  • Market Cap $72.5M
  • Description
  • Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...
More about TSHA
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.